Ongoing investigations into this medication are demonstrating significant outcomes regarding body composition . Initially intended for managing type 2 diabetes , this GLP-1 receptor agonist has shown https://bookmarkswing.com/story23229807/semaglutide-research-revealing-emerging-weight-loss-potential